Comment: Clarithromycin-digoxin interaction

Annals of Pharmacotherapy

Volumn 33, Issue 12, 1999, Pages 1375-

  Juurlink, David N ^a   Ito, Shinya ^b  

^a UNIVERSITY OF TORONTO   (Canada)

^b HOSPITAL FOR SICK CHILDREN   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CLARITHROMYCIN; CYCLOSPORIN; DIGOXIN; GLYCOPROTEIN P; PROPAFENONE; QUINIDINE; VERAPAMIL; WARFARIN;

AGING; ANTICOAGULATION; CELLULITIS; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG ELIMINATION; DRUG INTOXICATION; DRUG MECHANISM; DRUG MIXTURE; HEART ATRIUM FIBRILLATION; HEART VENTRICLE TACHYCARDIA; HUMAN; INFECTION; LETTER; PRIORITY JOURNAL;

ANTI-BACTERIAL AGENTS; CARDIOTONIC AGENTS; CLARITHROMYCIN; DIGOXIN; DRUG INTERACTIONS; HUMANS; P-GLYCOPROTEIN;

EID: 0033376346     PISSN: 10600280     EISSN: 15426270     Source Type: Journal    
DOI: 10.1177/106002809903301204     Document Type: Letter

References (7)

1. Gooderham MJ, Bolli P, Fernandez PG. Concomitant digoxin toxicity and warfarin interaction in a patient receiving clarithromycin. Ann Pharmacother 1999;33:796–9.
2. Okamura N, Hirai M, Tanigawara Y, Tanaka K, Yasuhara M, Ueda K, et al. Digoxin-cyclosporin A interaction: Modulation of the multidrug transporter P-glycoprotein in the kidney. J Pharmacol Exp Ther 1993;266:1614–9.
3. Woodland C, Verjee Z, Giesbrecht E, Koren G, Ito S. The digoxin-propafenone interaction: Characterization of a mechanism using renal tubular cell monolayers. J Pharmacol Exp Ther 1997;283:39–45.
4. Fromm MF, Kim RB, Stein CM, Wilkinson GR, Roden DM. Inhibition of P-glycoprotein-mediated drag transport: A unifying mechanism to explain the interaction between digoxin and quinidine. Circulation 1999;99:552–7.
5. Ito S, Woodland C, Harper PA, Koren G. The mechanism of the verapamil-digoxin interaction in renal tubular cells (LLC-PK1). Life Sci 1993;53:PL399–403.
6. Wakasugi H, Yano I, Ito T, Hashida T, Futami T, Nohara R, et al. Effect of clarithromycin on renal excretion of digoxin: Interaction with P-glycoprotein. Clin Pharmacol Ther 1998;64:123–8.
7. Redelmeier DA, Naylor CD, Brenneman FD, Sharkey PW, Tan SH, Juurlink DN. The risk of traumatic injury in elderly adults receiving lipid-lowering medications. Lancet (submitted for publication).